Canada Markets closed

NEC Corporation (NIPNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
41.320.00 (0.00%)
At close: 11:08AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close41.32
Open40.90
BidN/A x N/A
AskN/A x N/A
Day's Range41.32 - 41.32
52 Week Range37.12 - 57.50
Volume75
Avg. Volume98
Market Cap11.659B
Beta (5Y Monthly)N/A
PE Ratio (TTM)8.54
EPS (TTM)4.84
Earnings DateN/A
Forward Dividend & Yield0.86 (2.25%)
Ex-Dividend DateSept 29, 2022
1y Target EstN/A
  • Business Wire

    NEC and Juniper Networks Deploy Algeria Telecom’s Nationwide 5G-Ready IP Metro Network

    TOKYO & SUNNYVALE, Calif., May 25, 2022--NEC Corporation (NEC; TSE: 6701), a leading global IT and network transformation services provider, and Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced they have worked with Algeria Telecom, the leader in the Algerian telecommunications market, to roll out its modernized, nationwide IP metro commercial network to support current demand for increased capacity as well as future needs driven by 5G and FTTx.

  • Bloomberg

    Mastercard Begins Facial-Recognition Rollout With Retailers

    (Bloomberg) -- Mastercard Inc. has begun to trial a biometric payment system for brick-and-mortar stores, using facial recognition rather than contactless cards, smartphones or memorable PINs.Most Read from BloombergWalmart’s Troubles Should Have Everyone on High AlertA $5 Trillion ‘Wealth Shock’ Is Cracking Americans’ Nest EggsHow an Energy Expert Triggered Vladimir Putin With One WordAeroflot Is Back to the Future as Sanctions Ground Its AmbitionsPutin’s War Means Russia’s Rich Aren’t Welcome

  • Business Wire

    BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status

    WALTHAM, Mass., April 06, 2022--BostonGene today announced the completion of the $150 million Series B funding. NEC Corporation (NEC; TSE: 6701) led the financing with participation from Impact Investment Capital and Japan Industrial Partners. The capital will be used to scale BostonGene’s growth, including continued innovation, clinical and research partnerships, and international expansion. Further, leveraging NEC’s robust infrastructure, BostonGene and NEC intend to form a joint venture to br